JP2006516140A5 - - Google Patents

Download PDF

Info

Publication number
JP2006516140A5
JP2006516140A5 JP2004563641A JP2004563641A JP2006516140A5 JP 2006516140 A5 JP2006516140 A5 JP 2006516140A5 JP 2004563641 A JP2004563641 A JP 2004563641A JP 2004563641 A JP2004563641 A JP 2004563641A JP 2006516140 A5 JP2006516140 A5 JP 2006516140A5
Authority
JP
Japan
Prior art keywords
tested
compounds
found
examples
above assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2004563641A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516140A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/040126 external-priority patent/WO2004058148A2/en
Publication of JP2006516140A publication Critical patent/JP2006516140A/ja
Publication of JP2006516140A5 publication Critical patent/JP2006516140A5/ja
Ceased legal-status Critical Current

Links

JP2004563641A 2002-12-20 2003-12-16 有糸分裂キネシン阻害剤 Ceased JP2006516140A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43510202P 2002-12-20 2002-12-20
PCT/US2003/040126 WO2004058148A2 (en) 2002-12-20 2003-12-16 Mitotic kinesin inhibitors

Publications (2)

Publication Number Publication Date
JP2006516140A JP2006516140A (ja) 2006-06-22
JP2006516140A5 true JP2006516140A5 (https=) 2010-07-15

Family

ID=32682157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004563641A Ceased JP2006516140A (ja) 2002-12-20 2003-12-16 有糸分裂キネシン阻害剤

Country Status (6)

Country Link
US (1) US7622468B2 (https=)
EP (1) EP1581497A4 (https=)
JP (1) JP2006516140A (https=)
AU (1) AU2003297230B2 (https=)
CA (1) CA2509212A1 (https=)
WO (1) WO2004058148A2 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003299672B2 (en) * 2002-12-20 2010-02-25 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
WO2004109290A2 (en) * 2003-05-30 2004-12-16 Rosetta Inpharmatics Llc Methods for identifying modulators of kinesin activity
WO2006123182A2 (en) 2005-05-17 2006-11-23 Merck Sharp & Dohme Limited Cyclohexyl sulphones for treatment of cancer
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
AR064777A1 (es) 2007-01-10 2009-04-22 Inst Di Reserche D Biolog Mole Indazoles sustituidos con amida como inhibidores de poli (adp- ribosa) polimerasa (parp)
AR068888A1 (es) 2007-10-19 2009-12-16 Schering Corp Derivados de 1, 3, 4 - tiadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de la quinesina ksp.
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
US8859776B2 (en) 2009-10-14 2014-10-14 Merck Sharp & Dohme Corp. Substituted piperidines that increase p53 activity and the uses thereof
US8999957B2 (en) 2010-06-24 2015-04-07 Merck Sharp & Dohme Corp. Heterocyclic compounds as ERK inhibitors
CA2805265A1 (en) 2010-08-02 2012-02-09 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
WO2012024170A2 (en) 2010-08-17 2012-02-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
WO2012058210A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
EP2654748B1 (en) 2010-12-21 2016-07-27 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
EP2770987B1 (en) 2011-10-27 2018-04-04 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
WO2013165816A2 (en) 2012-05-02 2013-11-07 Merck Sharp & Dohme Corp. SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
WO2014052563A2 (en) 2012-09-28 2014-04-03 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
CN103804283B (zh) * 2012-11-06 2016-04-20 中国科学院大连化学物理研究所 一种制备1,2-二氢吡啶衍生物的方法
ME02925B (me) 2012-11-28 2018-04-20 Merck Sharp & Dohme Kompozicije i postupci za liječenje kancera
TW201429969A (zh) 2012-12-20 2014-08-01 Merck Sharp & Dohme 作爲hdm2抑制劑之經取代咪唑吡啶
WO2014120748A1 (en) 2013-01-30 2014-08-07 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
CN104756984B (zh) * 2015-03-30 2016-08-17 上海应用技术学院 多取代顺式二苯乙烯类化合物作为农用杀菌剂的应用
JOP20190055A1 (ar) 2016-09-26 2019-03-24 Merck Sharp & Dohme أجسام مضادة ضد cd27
US10975084B2 (en) 2016-10-12 2021-04-13 Merck Sharp & Dohme Corp. KDM5 inhibitors
CN118267470A (zh) 2017-04-13 2024-07-02 赛罗帕私人有限公司 抗SIRPα抗体
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
EP3706747B1 (en) 2017-11-08 2025-09-03 Merck Sharp & Dohme LLC Prmt5 inhibitors
WO2019148412A1 (en) 2018-02-01 2019-08-08 Merck Sharp & Dohme Corp. Anti-pd-1/lag3 bispecific antibodies
WO2020033288A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
US11981701B2 (en) 2018-08-07 2024-05-14 Merck Sharp & Dohme Llc PRMT5 inhibitors
WO2020033282A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
EP3833669A4 (en) 2018-08-07 2022-05-11 Merck Sharp & Dohme Corp. PRMT5 INHIBITORS
US12595248B2 (en) 2019-12-17 2026-04-07 Merck Sharp & Dohme Llc PRMT5 inhibitors
CN115003303B (zh) 2019-12-17 2024-03-08 默沙东公司 Prmt5抑制剂
JP7589247B2 (ja) 2019-12-17 2024-11-25 メルク・シャープ・アンド・ドーム・エルエルシー Prmt5阻害剤
EP4076460B1 (en) 2019-12-17 2026-01-21 Merck Sharp & Dohme LLC 1,4-dihydro-2h-spiro[isoquinoline-3,4'-piperidine derivatives as prmt5 inhibitors for the treatment of cancer
WO2026027944A1 (en) 2024-07-30 2026-02-05 Sairopa B.V. Anti-sirp alpha antibody formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
EP0322034A3 (en) * 1987-12-22 1991-01-02 Merck Sharp & Dohme Ltd. Methyl tetrahydropyridyl oxadiazoles
FR2662442A1 (fr) 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
EP0459568A3 (en) * 1990-05-31 1992-09-30 Merck Sharp & Dohme Ltd. Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
JP2000119250A (ja) * 1998-08-11 2000-04-25 Takeda Chem Ind Ltd 環状アミド化合物、その製造法、中間体及び除草剤
MXPA04012642A (es) * 2002-06-14 2005-03-23 Merck & Co Inc Inhibidores de la cinesina mitotica.
EP1556052A4 (en) * 2002-10-18 2006-11-02 Merck & Co Inc MITOTIC KINESINE HEMMER
AU2003299672B2 (en) * 2002-12-20 2010-02-25 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors

Similar Documents

Publication Publication Date Title
JP2006516140A5 (https=)
CY2024006I2 (el) Διαμινοπυριμιδινες ως ρ2χ3 και ρ2χ2/3 ανταγωνιστες
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
JP2004502858A5 (https=)
EP1693005A4 (en) ULTRASONIC UNIT AND ULTRASOUND SURVEY
CY2009007I2 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
IL229509A0 (en) Preparations containing chemically modified small molecules and processes using them
LT3718564T (lt) Nauji anti-il-13 antikūnai ir jų panaudojimas
EP1762234A4 (en) AMPK AKTIVATOR
NO20030514L (no) Kommersiell motor i bakgrunnen
ITMI20031127A0 (it) Anticorpi anti-hgf e loro uso
AU2003900878A0 (en) Improved sodar sounding in the lower atmosphere
EP2302383A3 (en) Docetaxel conjugates and immunogens for use in an immunoassay
EP1963840A4 (en) IMMUNOASSAY DEVICE AND KIT
NO20013352D0 (no) Anordning for sortering av marine organismer
EP1958792A4 (en) LIGHT-EMITTING WRITING DEVICE AND THIS INSERTING LIGHT-EMITTING DISPLAY
DE502004001120D1 (de) Sensorbauteil und nutzen zu seiner herstellung
EP1641431A4 (en) USES OF IL-12 AT THE HEMATOPOESIS
EP1682088A4 (en) ORAL MICROEMULSION COMPOSITION WITH BIPHENYLDIMETHYLDICARBOXYLATE AND SILYBIN
RU2004132147A (ru) Адаптоген
FR2852021B1 (fr) Methodes et outils pour le criblage d'arn actifs in cellulo
JP2004119933A5 (https=)
ITMO20040195A1 (it) 'kit per la raccolta e la collezione di figurine'.
IL157586A0 (en) Diagnostic compositions containing an antibody to a beta-arrestin, methods utilizing the same and kits containing the same
TW563863U (en) Imitated insect specimen structure